ArticleBritish journal of pharmacology2001

Inhibition of interleukin-12 production by auranofin, an anti-rheumatic gold compound, deviates CD4(+) T cells from the Th1 to the Th2 pathway.

T S Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.